l‐asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein–Barr virus infection
Authors:
- 19 July 2024
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 205 (4) , 1610-1614
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysisExperimental Hematology, 2023
- Updated guidelines for chronic active Epstein–Barr virus diseaseInternational Journal of Hematology, 2023
- How I treat T-cell chronic active Epstein-Barr virus diseaseBlood, 2018
- How we treat chronic active Epstein–Barr virus infectionInternational Journal of Hematology, 2017
- The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to L-asparaginaseLeukemia, 2006
- Selective apoptosis of natural killer‐cell tumours by l‐asparaginaseBritish Journal of Haematology, 2005
- The Human ATP-Binding Cassette (ABC) Transporter SuperfamilyGenome Research, 2001
- Characterization of a Novel Human Natural Killer-Cell Line (NK-YS) Established From Natural Killer Cell Lymphoma/Leukemia Associated With Epstein-Barr Virus InfectionBlood, 1998
- HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosisMedical and Pediatric Oncology, 1997
- Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosomeBlood, 1975